Long-term Effects of Prenatal 3'-azido-3'-deoxythymidine (AZT) Exposure on Intermale Aggressive Behaviour of Mice
Overview
Affiliations
Rationale: AZT treatment of seropositive pregnant women and their neonates has been widely used due to its effectiveness in reducing vertical transmission of HIV, but medium- and long-term effects of AZT on neurobehavioural development and adult responding are still poorly described.
Objective: The aim of the present study was to evaluate the long-term effects of prenatal AZT treatment on aggressive behaviour of adult male mice.
Methods: Pregnant CD-1 mice were given saline vehicle, 0.4, or 0.8 mg/ml AZT in their drinking water from gestation day 10 to delivery. Social-aggressive types of interaction were assessed in their male offspring following a 4-week isolation period. Two groups of subjects were used, each undergoing a different type of test: test 1 consisted of a single 20-min encounter with an isolated same-strain opponent on postnatal day (PND) 90, while in test 2 (PND 150) subjects were paired for 10 min for 5 consecutive days with a non-isolated opponent.
Results: Slight changes in both aggressive and defensive components of the male-specific agonistic pattern were evident only in test 1, AZT mice displaying a limited increase of aggressive behaviour compared to their controls.
Conclusions: Although the long-term effects of prenatal AZT on social behaviour are limited, they may be of some relevance for paediatricians in order to plan a follow-up of infants, children and adolescents exposed in utero to antiretroviral drugs.
McHenry M, Balogun K, McDonald B, Vreeman R, Whipple E, Serghides L J Int AIDS Soc. 2019; 22(4):e25275.
PMID: 30983111 PMC: 6462810. DOI: 10.1002/jia2.25275.
Neurotoxic effects of AZT on developing and adult neurogenesis.
Demir M, Laywell E Front Neurosci. 2015; 9:93.
PMID: 25852464 PMC: 4367529. DOI: 10.3389/fnins.2015.00093.
Zuena A, Giuli C, Pesciolini A, Tramutola A, Ajmone-Cat M, Cinque C PLoS One. 2013; 8(2):e55753.
PMID: 23409035 PMC: 3567094. DOI: 10.1371/journal.pone.0055753.
Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.
Sirois P, Huo Y, Williams P, Malee K, Garvie P, Kammerer B Pediatr Infect Dis J. 2013; 32(6):648-55.
PMID: 23340561 PMC: 3723344. DOI: 10.1097/INF.0b013e318284129a.
Antiretroviral therapy in pregnancy: a focus on safety.
Taylor G, Low-Beer N Drug Saf. 2001; 24(9):683-702.
PMID: 11522121 DOI: 10.2165/00002018-200124090-00004.